U.S. markets open in 8 hours 22 minutes
  • S&P Futures

    3,929.25
    +6.50 (+0.17%)
     
  • Dow Futures

    31,500.00
    +60.00 (+0.19%)
     
  • Nasdaq Futures

    11,933.00
    -2.50 (-0.02%)
     
  • Russell 2000 Futures

    1,780.10
    +7.30 (+0.41%)
     
  • Crude Oil

    110.55
    +0.96 (+0.88%)
     
  • Gold

    1,813.10
    -2.80 (-0.15%)
     
  • Silver

    21.42
    -0.13 (-0.60%)
     
  • EUR/USD

    1.0504
    +0.0038 (+0.37%)
     
  • 10-Yr Bond

    2.8860
    0.0000 (0.00%)
     
  • Vix

    30.96
    +4.86 (+18.62%)
     
  • GBP/USD

    1.2391
    +0.0049 (+0.40%)
     
  • USD/JPY

    128.8180
    +0.5210 (+0.41%)
     
  • BTC-USD

    29,096.78
    -733.73 (-2.46%)
     
  • CMC Crypto 200

    648.41
    -22.27 (-3.32%)
     
  • FTSE 100

    7,438.09
    -80.26 (-1.07%)
     
  • Nikkei 225

    26,447.56
    -463.64 (-1.72%)
     

2 Reasons to Buy AbbVie Stock, and 1 Reason to Sell

·4 min read
2 Reasons to Buy AbbVie Stock, and 1 Reason to Sell
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

With 2021 net revenue estimated at $56.2 billion, AbbVie (NYSE: ABBV) is one of the world's most successful pharmaceutical companies. Let's take a peek at two compelling reasons to buy the shares of AbbVie and one significant reason it might be better to avoid or sell -- so that you'll know whether any potential tribulations in the near future are worth the potential upside down the road. At the moment, AbbVie's shares are priced such that they are neither a bargain nor overpriced.